Arginyl-glutamine dipeptide attenuates experimental colitis by enhancing antioxidant function and inhibiting nuclear factor-kappaB

• DOI: 10.1039/c5ra16739f
• Publication Date: 2015-10-15T10:03:02Z
• Authors: Hua Yu; Mingjun Dong; Yidong Xu; Ning He; Xiaoyu Dai; Keqiang Li
• Keywords: 0301 basic medicine; 03 medical and health sciences; 3. Good health

This study aimed to investigate the effect and underlying mechanism of Arginyl-glutamine (AG) dipeptide on dextran sulfate sodium (DSS)-induced colitis by<italic>in vivo</italic>and<italic>in vitro</italic>models.